Phase 2 Clinical Trial of Attenuated Salmonella enterica Serovar Typhi Oral Live Vector Vaccine CVD 908-htrA in U.S. Volunteers

Salmonella enterica serovar Typhi strain CVD 908-htrA is a live attenuated strain which may be useful as an improved oral typhoid vaccine and as a vector for cloned genes of other pathogens. We conducted a phase 2 trial in which 80 healthy adults received one of two dosage levels of CVD 908-htrA in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tacket, Carol O., Sztein, Marcelo B., Wasserman, Steven S., Losonsky, Genevieve, Kotloff, Karen L., Wyant, Timothy L., Nataro, James P., Edelman, Robert, Perry, Judith, Bedford, Philip, Brown, David, Chatfield, Stephen, Dougan, Gordon, Levine, Myron M.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2000
Matèries:
Microbial Immunity and Vaccines
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC97267/
https://ncbi.nlm.nih.gov/pubmed/10678926
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars